Company profile: G-CON
1.1 - Company Overview
Company description
- Provider of off-site, prefabricated cleanroom units (PODs) for pharmaceutical development and manufacturing, including design, construction, installation and qualification, enabling faster deployment versus traditional cleanroom infrastructure to address rapidly changing requirements.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to G-CON
BrightSpec
HQ: United States
Website
- Description: Provider of analytical chemistry solutions using FT‑MRR and molecular rotational resonance spectroscopy for detailed molecular structure insights. Delivers quantum simulation software to predict and confirm rotational spectra, ultra‑high‑resolution measurements for precise identification and quantitation in complex mixtures, and rapid targeted analysis without front‑end separation for pharmaceutical and chemical applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BrightSpec company profile →
PharmaFluidics
HQ: Belgium
Website
- Description: Provider of integrated milli- to nano-engineered solutions for mixing, separation and reaction processes, offering high-quality, tailor-made designs. Products include μPAC Neo silicon-based HPLC columns for high-resolution separations; EASY-Spray and Double nanoViper columns for nano/capillary LC-MS and robust proteomics; MAbPac RP for intact protein characterization; Accucore 150 Amide HILIC for hydrophilic biomolecules/glycans.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PharmaFluidics company profile →
Janvier Labs
HQ: France
Website
- Description: Provider of rodent research models and services, including immunodeficient models for studies in infectious diseases, immune system mechanisms, vaccine development, and cancer immunotherapy; humanized NXG-HIS mice with human-like immune systems for preclinical oncology and immunology; metabolic disease models; aged C57BL/6JRj mice and WISTAR rats; customized genetic model support; and SOPF/SPF colony management and logistics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Janvier Labs company profile →
LevitasBio
HQ: United States
Website
- Description: Provider of label-free cellular analysis, isolation, and enrichment solutions using magnetic levitation. Offers LeviCell EOS (simultaneous processing of up to four samples) and LeviCell 1.0 for non-damaging examination and delivery of biological signatures, LeviSelect kits for lysis-free RBC and CD45+ depletion, and LeviMetrics AI software for sample characterization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LevitasBio company profile →
Multi Channel Systems
HQ: Germany
Website
- Description: Provider of precise electrophysiology measuring instrumentation and software for research groups at universities, including microelectrode arrays (Mesh MEA) and systems combining laser-based optoporation with MEAs for intracellular action potential recordings in cardiac monolayers and organoids, plus data acquisition, analysis and screening tools (Multi Channel Suite, Multiwell-Screen, CMOS-MEA-Control, Beta-Screen Experimenter).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Multi Channel Systems company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for G-CON
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to G-CON
2.2 - Growth funds investing in similar companies to G-CON
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for G-CON
4.2 - Public trading comparable groups for G-CON
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →